The ongoing COVID-19 pandemic is shining a bright spotlight on vaccine development. As numerous vaccines race through clinical trials, physicians and researchers continue to work on developing new vaccine technologies to ...
Aug 7, 2020
0
243
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led ...
Jul 30, 2020
0
11
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in ...
Jul 24, 2020
0
212
As the COVID-19 pandemic continues to impact health and livelihoods of millions, there is increasing attention focused on vaccine development. But an effective treatment has a critical role to play—before and after a vaccine ...
Jul 16, 2020
0
3
The T cells, along with antibodies, are an integral part of the human immune response against viral infections due to their ability to directly target and kill infected cells. A Singapore study has uncovered the presence ...
Jul 16, 2020
0
5069
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the ...
Jul 15, 2020
0
11
The novel coronavirus is not expected to disappear anytime soon. With physical distancing, virus testing, contact tracing, and potentially new therapeutics, we may be able to keep it partially at bay. But many eyes are looking ...
Jul 14, 2020
0
8
A vaccine to prevent COVID-19 is perhaps the best hope for ending the pandemic. Currently, there is no vaccine to prevent infection with the COVID-19 virus, but researchers are racing to create one.
Jul 8, 2020
0
5
Scientists have made significant steps in the development of vaccines that could be used to tackle COVID-19 in animals.
Jun 23, 2020
0
1
Researchers at UConn's Center of Excellence in Vaccine Research (CEVR) have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen. Their research was recently published ...
Jun 17, 2020
0
63
